Peter P.T. de Jaegere

Showing 1-20 of 58 articles

Coronary interventions

Validation of 3-Dimensional Quantitative Coronary Angiography based software to calculate Fractional Flow Reserve: Fast Assessment of STenosis severity (FAST)-study

Masdjedi K, van Zandvoort L, Balbi MM, Gijsen F, Ligthart J, Rutten M, E Lemmert ME, Wilschut J, Diletti R, de Jaegere P, Zijlstra F, Van Mieghem N, Daemen J

May 14, 2019 | 10.4244/EIJ-D-19-00466

Interventions for valvular disease

Tools and Techniques: Single access Balloon Aortic Valvuloplasty - An overview of contemporary technical improvements

Ooms J, van Wiechen M, Ziviello F, Kroon HG, Ben Ren B, Daemen J, de Jaegere P, Van Mieghem N

April 9, 2019 | 10.4244/EIJ-D-19-00074

The European Collaborative Project on Inflammation and Vascular Wall Remodeling in Atherosclerosis - Intravascular Ultrasound (ATHEROREMO-IVUS) study

de Boer S, Baran Y, Garcia-Garcia H, Eskin I, Lenzen M, Kleber M, Regar E, de Jaegere P, Ligthart J, van Geuns R, Lehtimaki T, Laaksonen R, Boersma E, Marz W, Halperin E, Serruys P, Koenig W

June 20, 2018 | 10.4244/EIJ-D-17-00180

Interventions for valvular disease

How should I treat a patient with a symptomatic and severe low-flow low-gradient aortic stenosis and an incidental abdominal aortic aneurysm?

Rahhab Z, Raa S, van der Ploeg N, Van Mieghem N, Verhagen H, de Jaegere P, Arsalan M, Kim W, Walther T, Tchétché D

July 20, 2017 | 10.4244/EIJ-D-16-00461

Interventions for valvular disease

Impact of permanent pacemaker on mortality after transcatheter aortic valve implantation: the PRAGMATIC (Pooled Rotterdam-Milan-Toulouse in Collaboration) Pacemaker substudy

Giustino G, van der Boon R, Molina-Martin de Nicolas J, Dumonteil N, Chieffo A, de Jaegere P, Tchétché D, Marcheix B, Millischer D, Cassagneau R, Carrié D, Van Mieghem N, Colombo A

October 20, 2016 | 10.4244/EIJV12I9A192

Interventions for valvular disease

MANTA, a novel plug-based vascular closure device for large bore arteriotomies: technical report

Van Gils L, Daemen J, Walters G, Sorzano T, Grintz T, Nardone S, Lenzen M, de Jaegere P, Roubin G, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12I7A147

Coronary interventions

Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries

Oemrawsingh R, Garcia-Garcia H, van Geuns R, Lenzen M, Simsek C, de Boer S, Van Mieghem N, Regar E, de Jaegere P, Akkerhuis K, Ligthart J, Zijlstra F, Serruys P, Boersma E

August 20, 2016

Interventions for valvular disease

Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial

Van Mieghem N, Van Gils L, Ahmad H, van Kesteren F, van der Werf H, Brueren G, Storm M, Lenzen M, Daemen J, van den Heuvel A, Tonino P, Baan Jr J, Koudstaal P.J., Schipper M, van der Lugt A, de Jaegere P

July 20, 2016 | 10.4244/EIJV12I4A84

Interventions for valvular disease

Does frame geometry play a role in aortic regurgitation after Medtronic CoreValve implantation?

Rodriguez-Olivares R, Faquir N, Rahhab Z, Geeve P, Maugenest A-M, van Weenen S, Ren B, Galema T, Geleijnse M, Van Mieghem N, van Domburg R, Bruining N, Schultz C, Lauritsch G, de Jaegere P

July 20, 2016 | 10.4244/EIJY15M08_02

Coronary interventions

Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study

Fam J, Felix C, van Geuns R, Onuma Y, Van Mieghem N, Karanasos A, van der Sijde J, De Paolis M, Regar E, Valgimigli M, Daemen J, de Jaegere P, Zijlstra F, Diletti R

May 16, 2016 | 10.4244/EIJV12I1A6

Interventions for valvular disease

Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies

Van Mieghem N, Rodriguez-Olivares R, Ben C. Ren B, Van Gils L, Maugenest A-M, Geleijnse M, Budde R, Vogelaar J, Verstraeten L, de Jaegere P

March 18, 2016 | 10.4244/EIJV11I12A273

Interventions for valvular disease

Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey

Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein AP, de Jaegere P, Tchétché D

February 12, 2016 | 10.4244/EIJV11I10A253

Interventions for valvular disease

Patient-specific image-based computer simulation for the prediction of valve morphology and calcium displacement after TAVI with the Medtronic CoreValve and the Edwards SAPIEN valve

Schultz C, Rodriguez-Olivares R, Bosmans J, Lefèvre T, De Santis G, Bruining N, Collas V, Dezutter T, Bosmans B, Rahhab Z, Faquir N, Watanabe Y, Segers P, Verhegghe B, Chevalier B, Van Mieghem N, De Beule M, Mortier P, de Jaegere P

January 20, 2016 | 10.4244/EIJV11I9A212

Rapid exchange ultra-thin microcatheter using fibre-optic sensing technology for measurement of intracoronary fractional flow reserve

Diletti R, Van Mieghem N, Valgimigli M, Karanasos A, Everaert B, Daemen J, van Geuns R, de Jaegere P, Zijlstra F, Regar E

August 20, 2015 | 10.4244/EIJY15M05_09

Rotational angiography with motion compensation: first-in-man use for the 3D evaluation of transcatheter valve prostheses

Schultz C, Lauritsch G, Van Mieghem N, Rohkohl C, Serruys P, van Geuns R, de Jaegere P

August 20, 2015 | 10.4244/EIJY14M06_08

Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve

Van Mieghem N, Rodriguez-Olivares R, Kappetein AP, de Jaegere P

July 20, 2015 | 10.4244/EIJY15M02_06

An objective and reproducible method for quantification of aortic regurgitation after TAVI

Schultz C, Slots T, Yong G, Aben J-P, Van Mieghem N, Swaans M, Rahhab Z, Faquir N, van Geuns R, Mast G, Zijlstra F, de Jaegere P

July 21, 2014 | 10.4244/EIJY14M05_06

How should I treat a patient with a stenosed bicuspid aortic valve and an unexpected finding during TAVI?

Rodriguez-Olivares R, van Geuns R, de Jong P, Van Mieghem N, de Jaegere P

April 22, 2014 | 10.4244/EIJV9I12A246

Transcatheter aortic valve replacement and vascular complications definitions

Van Mieghem N, Généreux P, van der Boon R, Kodali S, Head S, Williams M, Daneault B, Kappetein AP, de Jaegere P, Leon M, Serruys P

March 20, 2014 | 10.4244/EIJV9I11A222

Occurrence, fate and consequences of ventricular conduction abnormalities after transcatheter aortic valve implantation

Houthuizen P, van der Boon R, Urena M, Van Mieghem N, Brueren G, Poels T, Van Garsse L, Rodés-Cabau J, Prinzen F, de Jaegere P

February 20, 2014 | 10.4244/EIJV9I10A194

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

New this week: Insights from an International CTO Registry

October 22, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Editorial

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Free access

The EuroIntervention health check 2019

October 4, 2019

Free Access

Last week's JAA: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Peter P.T. de Jaegere

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke